Status:
UNKNOWN
Cognitive Behavioral Therapy Based on Virtual Reality and Biofeedback Technology
Lead Sponsor:
Nanjing Medical University
Conditions:
Virtual Reality Exposure Therapy
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
The subjects were randomly assigned to VR treatment group and imaginary leak treatment group. In the VR treatment group, there were six VR exposure experiences, ranging from low to high levels of expo...
Detailed Description
The study recruited 60 patients with Acrophobia and randomly assigned them to the VR treatment group and the imaginary exposure treatment group. Recruitment conditions for Acrophobia: The Acrophobia q...
Eligibility Criteria
Inclusion
- 18-55 years old; 2.The anxiety scale in AQ scored more than 45.45 points ; 3.Meeting the DSM-IV criteria for specific phobia.
Exclusion
- Other current or recent mental disorders, such as post-traumatic stress disorder;
- Other physical diseases (such as heart disease and epilepsy) that may affect treatment;
- Pregnancy or lactation;
- No effect of psychotropic drugs or psychotherapy or prior exposure to heightphobia within 6 months (2013).
Key Trial Info
Start Date :
October 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04107532
Start Date
October 1 2019
End Date
October 1 2020
Last Update
September 27 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.